NCT01946711View on ClinicalTrials.gov

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 28, 2013

Primary Completion Date

February 3, 2020

Study Completion Date

June 21, 2021

Conditions
RhinosinusitisChronic Polyposis
Interventions
DRUG

Budesonide

Inhalation

DRUG

Budesonide

Nasal spray

Trial Locations (4)

37075

University Göttingen, Göttingen

55131

UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz, Mainz

81377

University LMU Munich, Munich

83022

HNO-Zentrum Mangfall-Inn, Rosenheim

Sponsors

Lead Sponsor

Pari Pharma GmbH
All Listed Sponsors
lead

Pari Pharma GmbH

INDUSTRY

NCT01946711 - Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi | Biotech Hunter | Biotech Hunter